Elimination of TB in India by 2025 a Tough Task: The Global Fund

Tuberculosis (TB) is the most significant public health challenge in India and eradicating TB by 2025 could be a tough task.

While the government's goal of ending tuberculosis (TB) by 2025 in India is worthy of applause, it is "tough" and "very stretching," given where the country stands currently, says a top executive at the Switzerland-based non-profit The Global Fund.

Tuberculosis - Spread - Symptoms - Diagnosis - Treatment - FAQs
Tuberculosis, caused by Mycobacterium tuberculosis, primarily affects the lung. It may spread to other organs.

‘India currently has the world's highest burden of tuberculosis (TB). Ending TB by 2025 in India is a tough challenge. However, early diagnoses and timely treatment could be the cornerstone in the fight against TB.’
Read More..

Tweet it Now

India currently has the world's highest burden of TB, with 27 percent of all global cases and over 30 percent of all deaths worldwide.

In March 2017, Prime Minister Narendra Modi announced India's target for the complete elimination of TB by 2025, five years ahead of global target of 2030.

Elimination of TB will mean there should be less than one case of TB for a population of 10 lakh by 2025, according to the World Health Organisation (WHO).

Diet in Tuberculosis | Tuberculosis Diet
Patients with tuberculosis should eat a healthy diet so that they build up their immunity to fight against tuberculosis.

"The biggest challenge in fighting infectious disease in India is TB," Peter Sands, Executive Director of the Global Fund to Fight AIDS, Tuberculosis, and Malaria, told IANS on Thursday.

"2025 is a tough challenge, given where India stands and is very stretching, as it isn't far away," Sands added.

Extra Pulmonary Tuberculosis - Symptoms, Signs, Causes, Risk factors, Treatment
Extra pulmonary tuberculosis is infection of tissues and organs other than the lungs by mycobacterium tuberculosis and related organisms.

However, he noted that it is great to have a demanding an ambitious goal and "since the announcement, there has been a marked acceleration in the progress against TB."

"I would applaud the leadership and action being taken. The government is showing a will and determination to realize the ambitious goal," Sand stressed.

Tuberculosis Treatment Time Could Be Lessened by Higher Doses of Rifampin
Tuberculosis (TB) bacteria are killed effectively by higher doses of rifampin, one of the most potent of the four TB therapy drugs currently used to cure the disease

The Global Fund has been active since 2002 and have partnered with the government in the fight against HIV, TB, and Malaria.

Since 2002, the non-profit has disbursed $2.1 billion in various programmes to fight HIV, TB, and malaria and strengthen health systems in India. For the 2017-2019-allocation period, the organization has allocated $500 million - the largest proportion of it is focused on TB.

"One of the biggest challenges in the fight against TB are the 3.6 million "missing" people with active TB - people who are undiagnosed, unreported and untreated each year, contributing to ongoing transmission.

"Without treatment, a person with active TB can spread the disease to as many as 15 others," Sands said.

But, the new indicators are encouraging, he said. TB notification in India has increased from 1.7 million in 2015 to 2.15 million in 2018.

"If we have to beat the epidemic, we need to see the continued trajectory, decreases in the proportion of people falling ill with TB, and getting early diagnoses and treatment," Sands told IANS.

Although India accounts for 4 percent of the estimated global malaria cases and 68 percent of reported cases in South-East Asia, it has halved since 2000.

On HIV, Sands maintained that while India has made progress, there is still significant work to be done.

"Overcoming barriers to access to marginalized communities, especially to women in the remote areas, by leveraging the ASHA network and mobile clinics could help in the fight against the epidemics," Sands said.

Source-IANS